(Q44251231)

1 December 2017

Sucralfate diminishes basal acid output without affecting gastrin, H. pylori or gastritis in duodenal ulcer patients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

13 October 2022

1 reference

Helicobacter infection

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1600044

13 October 2022

author name string

S. F. Moss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1600044

13 October 2022

D. M. Thomas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1600044

13 October 2022

K. Ayesu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1600044

13 October 2022

S. Levi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1600044

13 October 2022

J. Calam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1600044

13 October 2022

language of work or name

English

0 references

publication date

1 April 1992

1 reference

full work available at URL

1 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1992.tb00268.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1992.tb00268.x/fullpdf

13 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Alimentary Pharmacology & Therapeutics

13 October 2022

published in

1 reference

1 December 2017

6

1 reference

1 December 2017

2

1 reference

1 December 2017

251-258

1 reference

The clinical significance of Campylobacter pylori

1 December 2017

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate

13 October 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

13 October 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

13 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study

13 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism

13 October 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer

13 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Initial therapy and relapse of duodenal ulcer: possible acid secretory mechanisms

13 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Why do ulcers heal with sucralfate?

13 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Implications of sucralfate-induced ulcer healing and relapse

13 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori

13 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Clinical Tests of Gastric Secretion

13 October 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine

13 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy

13 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Effect of bismuth subcitrate and sucralfate on rat duodenal and human gastric bicarbonate secretion in vivo

13 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Sucralfate and gastric bicarbonate

13 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Therapeutic aspects of prostaglandins in the treatment of peptic ulcer disease

13 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

13 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

Reversible Sustained Increase of Gastrin and Gastric Acid Secretion in a Subgroup of Duodenal Ulcer Patients on Long-Term Treatment with H2 Antagonists

13 October 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1992.TB00268.X

13 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1600044

13 October 2022

1 reference